These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 8317478)
1. Monoclonal antibodies against the muscle-specific N-terminus of dystrophin: characterization of dystrophin in a muscular dystrophy patient with a frameshift deletion of exons 3-7. Le TT; Nguyen TM; Love DR; Helliwell TR; Davies KE; Morris GE Am J Hum Genet; 1993 Jul; 53(1):131-9. PubMed ID: 8317478 [TBL] [Abstract][Full Text] [Related]
2. Use of epitope libraries to identify exon-specific monoclonal antibodies for characterization of altered dystrophins in muscular dystrophy. Nguyen TM; Morris GE Am J Hum Genet; 1993 Jun; 52(6):1057-66. PubMed ID: 7684887 [TBL] [Abstract][Full Text] [Related]
3. Characterization of genetic deletions in Becker muscular dystrophy using monoclonal antibodies against a deletion-prone region of dystrophin. Le Thiet Thanh ; Nguyen Thi Man ; Hori S; Sewry CA; Dubowitz V; Morris GE Am J Med Genet; 1995 Aug; 58(2):177-86. PubMed ID: 8533812 [TBL] [Abstract][Full Text] [Related]
4. Characterization of revertant muscle fibers in Duchenne muscular dystrophy, using exon-specific monoclonal antibodies against dystrophin. Thanh LT; Nguyen TM; Helliwell TR; Morris GE Am J Hum Genet; 1995 Mar; 56(3):725-31. PubMed ID: 7887428 [TBL] [Abstract][Full Text] [Related]
5. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy. Winnard AV; Klein CJ; Coovert DD; Prior T; Papp A; Snyder P; Bulman DE; Ray PN; McAndrew P; King W Hum Mol Genet; 1993 Jun; 2(6):737-44. PubMed ID: 8353493 [TBL] [Abstract][Full Text] [Related]
6. A truncated dystrophin lacking the C-terminal domains is localized at the muscle membrane. Helliwell TR; Ellis JM; Mountford RC; Appleton RE; Morris GE Am J Hum Genet; 1992 Mar; 50(3):508-14. PubMed ID: 1539591 [TBL] [Abstract][Full Text] [Related]
7. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy. Arahata K; Beggs AH; Honda H; Ito S; Ishiura S; Tsukahara T; Ishiguro T; Eguchi C; Orimo S; Arikawa E J Neurol Sci; 1991 Feb; 101(2):148-56. PubMed ID: 2033400 [TBL] [Abstract][Full Text] [Related]
8. Dystrophin in frameshift deletion patients with Becker muscular dystrophy. Gangopadhyay SB; Sherratt TG; Heckmatt JZ; Dubowitz V; Miller G; Shokeir M; Ray PN; Strong PN; Worton RG Am J Hum Genet; 1992 Sep; 51(3):562-70. PubMed ID: 1496988 [TBL] [Abstract][Full Text] [Related]
9. Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production. Winnard AV; Mendell JR; Prior TW; Florence J; Burghes AH Am J Hum Genet; 1995 Jan; 56(1):158-66. PubMed ID: 7825572 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies for dystrophin analysis. Epitope mapping and improved binding to SDS-treated muscle sections. Nguyen TM; Ginjaar IB; van Ommen GJ; Morris GE Biochem J; 1992 Dec; 288 ( Pt 2)(Pt 2):663-8. PubMed ID: 1281410 [TBL] [Abstract][Full Text] [Related]
11. Exon skipping and translation in patients with frameshift deletions in the dystrophin gene. Sherratt TG; Vulliamy T; Dubowitz V; Sewry CA; Strong PN Am J Hum Genet; 1993 Nov; 53(5):1007-15. PubMed ID: 8213828 [TBL] [Abstract][Full Text] [Related]
12. Deletions in the 5' region of dystrophin and resulting phenotypes. Muntoni F; Gobbi P; Sewry C; Sherratt T; Taylor J; Sandhu SK; Abbs S; Roberts R; Hodgson SV; Bobrow M J Med Genet; 1994 Nov; 31(11):843-7. PubMed ID: 7853367 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies for clinical trials of Duchenne muscular dystrophy therapy. Le TL; Nguyen TM; Morris GE Neuromuscul Disord; 2014 Mar; 24(3):195-200. PubMed ID: 24361045 [TBL] [Abstract][Full Text] [Related]
14. Molecular deletion patterns in Turkish Duchenne and Becker muscular dystrophy patients. Dinçer P; Topaloğlu H; Ayter S; Ozgüç M; Taşdemir HA; Renda Y Brain Dev; 1996; 18(2):91-4. PubMed ID: 8733896 [TBL] [Abstract][Full Text] [Related]
15. Immunostaining of dystrophin and utrophin in skeletal muscle of dystrophinopathies. Sahashi K; Ibi T; Suoh H; Nakao N; Tashiro M; Marui K; Arahata K; Sugita H Intern Med; 1994 May; 33(5):277-83. PubMed ID: 7949630 [TBL] [Abstract][Full Text] [Related]
16. A case of Becker muscular dystrophy resulting from the skipping of four contiguous exons (71-74) of the dystrophin gene during mRNA maturation. Patria SY; Alimsardjono H; Nishio H; Takeshima Y; Nakamura H; Matsuo M Proc Assoc Am Physicians; 1996 Jul; 108(4):308-14. PubMed ID: 8863344 [TBL] [Abstract][Full Text] [Related]
17. Two distinct mutations in a single dystrophin gene: identification of an altered splice-site as the primary Becker muscular dystrophy mutation. Wilton SD; Johnsen RD; Pedretti JR; Laing NG Am J Med Genet; 1993 Jun; 46(5):563-9. PubMed ID: 8322822 [TBL] [Abstract][Full Text] [Related]
18. Alternative dystrophin gene transcripts in golden retriever muscular dystrophy. Schatzberg SJ; Anderson LV; Wilton SD; Kornegay JN; Mann CJ; Solomon GG; Sharp NJ Muscle Nerve; 1998 Aug; 21(8):991-8. PubMed ID: 9655116 [TBL] [Abstract][Full Text] [Related]